Table 2.
Baseline characteristics and symptoms of the groups with or without QFDYG.
| ST(n = 35) | ST+QFDYG (n = 49) | P | |
|---|---|---|---|
| Age, years | 48 (39, 53) | 57 (49.5, 65.5) | 0.137 |
| Sex (male/female) | 22/13 | 28/21 | 0.599 |
| Clinical classification (mild/severe) | 31/4 | 37/12 | 0.133 |
| Signs and symptoms | |||
| Fever (> 37.2°C) | 30 (85.71%) | 41 (83.67%) | 0.799 |
| Cough | 32 (91.42%) | 45 (91.83%) | 0.947 |
| Mild insomnia | 29 (82.86%) | 43 (87.76%) | 0.527 |
| Chest CT | 31(88.57%) | 44 (91.84%) | 0.858 |
| Laboratory indices | |||
| Leukocyte count (×109/L) | 4.23 (3.86, 4.79) | 6.23 (4.93, 9.26) | 0.058 |
| Neutrophil count (×109/L) | 2.57 (2.45, 3.35) | 4.69 (3.40, 7.36) | 0.024 |
| Lymphocyte count (×109/L) | 1.38 (0.71, 1.38) | 1.19 (1.06, 1.21) | 0.79 |
| Hs-CRP (mg/L) | 9.00 (9.00, 12.29) | 9.70 (2.40, 9.80) | 0.886 |
| Underlying diseases | |||
| Diabetes | 8 (22.86%) | 13 (26.53%) | 0.701 |
| Hypertension | 9 (25.71%) | 12 (24.49%) | 0.898 |
| Hyperlipemia | 5 (14.29%) | 8 (16.33%) | 0.799 |
| Coronary disease | 3 (8.57%) | 5 (10.20%) | 0.802 |
| Chronic hepatitis B | 2 (5.71%) | 4 (8.16%) | 0.693 |